Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of TU-NMS questionnaire and benefit of botulinum toxin on non-motor symptoms in primary craniocervical dystonia
TCTR20251124004Phase 4Completed
- Sponsor
- N/A
- Start
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of neuronox in cervical dystonia (CD), sponsored by N/A. Started Jan 2023; status: completed.
02
Drugs
neuronox
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on TCTR20251124004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251124004.